However, the release of various DAMPs, including ATP, HMGB1 and IL-1α, from dead tumor cells activates the NLRP3 inflammasome in DCs, which can lead to resistance to chemotherapy and promote tumor growth (66). The gene discussed is NLRP3; the disease is neoplasm.